Improving renoprotective effects by adding piperazine ferulate and angiotensin receptor blocker in diabetic nephropathy: a meta-analysis of randomized controlled trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
https://link.springer.com/content/pdf/10.1007/s11255-021-02927-2.pdf
Reference38 articles.
1. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME (2014) Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 64(4):510–533
2. Tomino Y, Gohda T (2015) The prevalence and management of diabetic nephropathy in Asia. Kidney Dis 1(1):52–60
3. Albvr VR, Tan SH, Candasamy M, Bhattamisra SK (2019) Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr 13(1):754–762
4. Tang SC, Chan GC, Lai KN (2016) Recent advances in managing and understanding diabetic nephropathy. F1000Research. https://doi.org/10.12688/f1000research.7693.1
5. Pofi R, Di Mario F, Gigante A, Rosato E, Isidori AM, Amoroso A, Cianci R, Barbano B (2016) Diabetic nephropathy: focus on current and future therapeutic strategies. Curr Drug Metab 17(5):497–502
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis;European Journal of Pharmacology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3